(Q34237350)

31 July 2017

Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis (English)

1 reference

31 July 2017

0 references

0 references

1 reference

3

Merri Pendergrass

1 reference

31 July 2017

Rajesh Garg

1

1 reference

PubMed ID

20682680

31 July 2017

William Chen

series ordinal

2

1 reference

PubMed ID

20682680

31 July 2017

language of work or name

English

0 references

publication date

3 August 2010

1 reference

31 July 2017

1 reference

31 July 2017

33

1 reference

31 July 2017

11

1 reference

31 July 2017

2349-2354

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

31 July 2017

start time

28 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963493

Exenatide-induced acute pancreatitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963493

Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963493

Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963493

A chronic disease score from automated pharmacy data

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963493

Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963493

GLP-1-based therapy for diabetes: what you do not know can hurt you.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963493

Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963493

Exenatide and acute pancreatitis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963493

Exenatide (exendin-4)-induced pancreatitis: a case report.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963493

Exenatide and rare adverse events

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20682680

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20682680

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2337/DC10-0482

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

PubMed ID

20682680